Decreased transforming growth factor β type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression

Cancer Research

Volumn 57, Issue 9, 1997, Pages 1638-1643

  Zhang, Tong ^a   Nanney, Lillian B ^a,c   Peeler, Mark O ^a   Williams, Christopher S ^a   Lamps, Laura ^a   Heppner, Kathleen J ^a   DuBois, Raymond N ^a,b,c   Beauchamp, R Daniel ^a,b,d  

^a Department of Surgery ^*  (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; ISOENZYME; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADENOMA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; CYTOSKELETAL PROTEINS; IN SITU HYBRIDIZATION; INTESTINAL NEOPLASMS; INTESTINES; MICE; MICE, MUTANT STRAINS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0030953159     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Saltis, J. TGF-β: receptors and cell cycle arrest. Mol. Cell. Endocrinol., 116: 227-232, 1996.
2. Miyazono, K., Ten Dijke, P., Ichijo, H., and Heldin, C. H. Receptors for transforming growth factor β. Adv. Immunol., 55: 181-220, 1994.
3. Avery, A., Paraskeva, C., Hall, P., Flanders, K. C., Sporn, M., and Moorghen, M. TGF-β expression in the human colon: differential immunostaining along crypt epithelium. Br. J. Cancer, 68: 137-139, 1993.
4. Norgaard, P., Hougaard, S., Poulsen, H. S., and Spang-Thomsen, M. Transforming growth factor β and cancer. Cancer Treat. Rev., 21: 367-403, 1995.
5. Friess, H., Yamanaka, Y., Buchler, M., Ebert, M., Beger, H. G., Gold, L. I., and Korc, M. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology, 105: 1846-1856, 1993.
6. Azuma, M., Yuki, T., Tamatani, T., Motegi, K., Yoshida, H., and Sato, M. Lack of expression of transforming growth factor-β type II receptor associated with malignant progression in human salivary gland cell clones. Int. J. Cancer, 66: 802-805, 1996.
7. Myeroff, L. L., Parsons, R., Kim, S. J., Hedrick, L., Cho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., Park, K., Bang, Y-J., Lee, H. Y., Park, J-G., Lynch, H. T., Roberts, A. B., Vogelstein, B., and Markowitz, S. D. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55: 5545-5547, 1995.
8. Hahn, S. A., Schutte, M., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
9. Riggins, G. J., Thiagalingam, S., Rozenblum, R., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Mad-related genes in the human. Nat. Genet., 13: 347-349, 1996.
10. Munoz-Antonia, T., Li, X., Reiss, M., Jackson, R., and Antonia, S. A. Mutation in the transforming growth factor β type II receptor gene promoter associated with loss of gene expression. Cancer Res., 56: 4831-4835, 1996.
11. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
12. Townsend, C. M., Jr., and Beauchamp, R. D. New developments in colorectal cancer. Curr. Opin. Gastroenterol., 11: 36-42, 1995.
13. Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., and Kinzler, K. W. APC mutations occur early during colorectal tumorigenesis. Nature (Lond.), 359: 235-237, 1992.
14. Miyoshi, Y., Nagase, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., Aoki, T., Miki, Y., Mori, T., and Nakamura, Y. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet., 1: 229-233, 1992.
15. Taso, J., and Shibata, D. Further evidence that one of the earliest alterations in colorectal carcinogenesis involves APC. Am. J. Pathol., 145: 531-534, 1994.
16. Su, L. K., Kinzler, K. W., Vogelstein, B., Preisenger, A. C., Moser, A. R., Luongo, C., Gould, K. A., and Dove, W. F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (Washington DC), 256: 668-670, 1992.
17. Zhang, T., Nanney, L. B., Luongo, C., Lamps, L., Heppner, K. J., DuBois, R. N., and Beauchamp, R. D. Concurrent overexpression of cyclin D1 and cdk4 in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res., 57: 169-175, 1997.
18. Ko, T. C., Sheng, H. M., Reisman, D., Thompson, E. A., and Beauchamp, R. D. Transforming growth factor-β1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene, 10: 177-184, 1995.
19. Ewen, M. E., Sluss, H. K., Whitehouse, L. L., and Livingston, D. M. TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell, 74: 1009-1020, 1993.
20. Dietrich, W. F., Lander, E. S., Smith, J. S., Moser, A. R., Gould, K. A., Luongo, C., Borenstein, N., and Dove, W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75: 631-639, 1993.
21. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
22. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994.
23. 1 regulation in human head and neck cancer. Cancer Res., 55: 949-956, 1995.
24. Bartkova, J., Lukas, J., Strauss, M., and Bartek, J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10: 775-778, 1995.
25. He, J., Olson, J. J., and James, C. D. Lack of p161NK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res., 55: 4833-4836, 1995.
26. Zhao, J., and Buick, R. N. Regulation of transforming growth factor β receptors in H-ras oncogene-transformed rat intestinal epithelial cells. Cancer Res., 55: 6181-6188, 1995.
27. Kalkhoven, E., Roelen, B. A., de Winter, J. P., Mummery, C. L., van den Eijnden-van Raaij, A. J., van der Saag, P. T., and van der Burg, B. Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth & Differ., 6: 1151-1161, 1995.
28. Winesett, M. P., Ramsey, G. W., and Barnard, J. A. Type II TGF-β receptor expression in intestinal cell lines and in the intestinal tract. Carcinogenesis (Lond.), 17: 989-995, 1996.
29. Markowitz, S. D., Myeroff, L., Cooper, M. J., Traicoff, J., Kochera, M., Lutterbaugh, J., Swiriduk, M., and Willson, J. K. A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes but progresses to tumorigenicity and transforming growth factor-β independence without inactivating the p53 tumor suppressor gene. J. Clin. Invest., 93: 1005-1013, 1994.
30. Manning, A. M., Williams, A. C., Game, S. M., and Paraskeva, C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene, 6: 1471-1476, 1991.
31. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
32. Parsons, R., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res., 55: 5548-5550, 1995.
33. Lu, S. L., Akiyama, Y., Nagasaki, H., Saitoh, K., and Yuasa, Y. Mutations of the transforming growth factor-β type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem. Biophys. Res. Commun., 216: 452-457, 1995.
34. Wang, J., Sun, L-Z., Myeroff, L., Wang, X-F., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K., and Brattain, M. G. Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270: 22044-22049, 1995.
35. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Hyeja, K., Tsui, L. C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal cancer. Cell, 86: 543-552, 1996.
36. Luongo, C., Moser, A. R., Gledhill, S., and Dove, W. F. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res., 54: 5947-5952, 1994.
37. Δ716 knockout mice. Cancer Res., 57: 1644-1649, 1997.